The rising demand for GLP-1 receptor agonists like Ozempic and Wegovy has prompted significant interest in their benefits and risks. While these medications are linked to effective weight loss and may reduce risks of dementia and heart issues, concerns about overuse and the potential for counterfeits have surfaced, leading the FDA to issue warnings for users. Compounding pharmacies, which offer custom formulations, have gained popularity, but their safety is under scrutiny. As more Americans turn to these injections, the medical community is grappling with questions about long-term use, health implications, and the emerging shadow market for these drugs. Experts are eager to outline both the pros and cons as the conversation around weight loss medications evolves.